European Pharmaceutical Review

AUGUST 19, 2022

percent compound annual growth rate (CAGR) of the market include the increasing commercialisation of generics and emerging technologies and small biotechs with limited or no production capabilities driving development in the biopharmaceutical sector. According to the report, the packaging segment of the market will be worth $15.6

Packaging 90

Packaging Compounding 90

European Pharmaceutical Review

DECEMBER 21, 2022

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones.

Compounding 76

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 76

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 6, 2023

C global warming scenario by 2030, which is widely acknowledged to be necessary to avoid the worst impacts of climate change. solvent selection, inhaler propellant replacement, and packaging design) to employee travel and commute policy (e.g., recycled content in packaging, reduction of packaging weights).

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52